“This partnership allows us to take a focused, market-led approach in Europe,” said Checkerspot CEO John Krzywicki. “By working directly with La Fabrique Végétale, we can collaborate closely with ...

Patients living with seronegative gMG continue to face limited treatment options and there remains a significant need to meaningfully improve their lives. The FDA’s acceptance of our sBLA with ...

Basilea is joining INCATE as an industry partner, bringing extensive preclinical, clinical, and commercial expertise in anti-infectives and, for the first time, expanding INCATE’s scope to include ...

MDR Certification Achieved Kuros also announced that MagnetOs Granules and MagnetOs Putty received certification under the European Union Medical Device Regulation (MDR), on December 22, 2025. MDR ...

Both the Wegovy pill and Wegovy shot contain semaglutide, the same FDA-approved active ingredient working through identical GLP-1 receptor agonism. The distinction lies entirely in how the medication ...

According to analysis of Google Trends data from May through July 2025 published by health platform Hers, weight loss-related search interest increased over 26% year-over-year. Tennessee led all U.S.

The phrases "best electrolyte supplement" and "top hydration packets" are used in this report to reflect common consumer search behavior in 2026. This analysis does not rank products, verify outcomes, ...

As Novo Nordisk launches first FDA-approved oral weight loss medication, independent examination evaluates Ro's direct-to-patient distribution model, pricing transparency, and telehealth access ...

The Company expects to provide further information regarding its full year 2026 financial guidance on its fourth quarter earnings call in February.

NEW HYDE PARK, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- CareMed ®, an independent specialty pharmacy, has been selected as a pharmacy partner by Cytokinetics for MYQORZO™ ( aficamten ), indicated for ...

About the FALCON Trial FALCON is a first-in-human, open-label, multi-center Phase 1b clinical trial designed to evaluate the safety and tolerability of SGT-212 in participants aged 18-40 who have been ...

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...